Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea · Delayed Price · Currency is KRW 1,597.00
+15.00 (0.95%)
Dec 10, 2025, 3:30 PM KST
Xcell Therapeutics Market Cap
Xcell Therapeutics has a market cap or net worth of 17.3 billion as of December 10, 2025. Its market cap has decreased by -66.49% in one year.
Market Cap
17.30B
Enterprise Value
22.45B
Revenue
1.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,597.00
Market Cap Chart
Since July 15, 2024, Xcell Therapeutics's market cap has decreased from 90.22B to 17.30B, a decrease of -80.82%. That is a compound annual growth rate of -69.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 10, 2025 | 17.47B | -60.64% |
| Dec 30, 2024 | 44.38B | -50.80% |
| Jul 15, 2024 | 90.22B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.96T |
| Celltrion | 40.11T |
| ALTEOGEN | 24.41T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.49T |
| Yuhan | 8.76T |
| LigaChem Biosciences | 6.75T |
| Peptron | 6.65T |